Institute Bergonie

Bordeaux 33076

0 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Solid Tumors, Chemotherapy-induced Peripheral Neuropathy, Fallopian Tube Cancer, Giant Cell Glioblastoma, Glioblastoma, Glioblastoma With Oligodendroglial Component, Gliosarcoma, Haematological Malignancy, Higher-risk Myelodysplastic Syndrome, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer

Studies at this site

• Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies — Recruiting now
• Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma — Stopped early
• Study to Evaluate CCS1477 in Advanced Tumours — Completed
• Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) — Running, not enrolling
• Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) — Completed
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) — Completed
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed